Midwives' and Women's Perception on Moyo Fetal Heart Rate Monitor for Intrapartum Fetal Heart Rate Monitoring; A Cross-Sectional Study.
Moyo
fetal heart rate
labor
midwives
women
Journal
Medical devices (Auckland, N.Z.)
ISSN: 1179-1470
Titre abrégé: Med Devices (Auckl)
Pays: New Zealand
ID NLM: 101566041
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
12
2019
accepted:
13
02
2020
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
8
4
2020
Statut:
epublish
Résumé
The annual global neonatal mortality stands at 2.5 million deaths, 1 million of them dying within the first day of life. An additional 2.6 million are stillborn globally, the majority of them due to intrapartum events. Optimal fetal heart rate (FHR) monitoring has the potential to timely detect fetuses at risk and, if coupled with timely obstetric responses may save more newborns. Moyo is a new Doppler with nine crystals capable of monitoring FHR both intermittently and continuously. To assess women's and midwives' opinions on the use of Moyo for intrapartum FHR monitoring. We conducted a cross-sectional study using a structured questionnaire to assess women's and midwives' perception. Women who gave birth at the hospital who used Moyo were interviewed using a questionnaire immediately before discharge from the hospital. Twenty-eight midwives who have been using Moyo for more than 6 months were also interviewed using a structured questionnaire. Data were analyzed using excel and result presented in figures. In total 113 postpartum women who were monitored using Moyo were interviewed before discharge. Out of these, 46 (40.7%) were first-time mothers and the rest were multipara. In total, 95 women (84.1%) used Moyo and other devices for FHR monitoring, 81 (72%) said Moyo was better than Fetoscopes and handheld Doppler, two-third 75 (66.4%) felt that Moyo was comfortable and 93 (82.3%) would like Moyo to be used on them in the future. Out of 28 midwives, 11 (39.3%) used Moyo continuous only, 3 (10.7%) used Moyo intermittently only and 14 (50.0%) used both intermittent and continuous. Thirteen (46.4%) midwives prefer to use Moyo both intermittent and continuous. Sixteen (55.6%) said Moyo was effective, 21 (75%) felt comfortable to use Moyo, and 13 (46.4%) said Moyo was easy to use. The majority of midwives and women who used Moyo felt that Moyo was comfortable for intrapartum FHR monitoring. Moyo can be used both intermittently and continuously depending on the user's preferences.
Sections du résumé
BACKGROUND
BACKGROUND
The annual global neonatal mortality stands at 2.5 million deaths, 1 million of them dying within the first day of life. An additional 2.6 million are stillborn globally, the majority of them due to intrapartum events. Optimal fetal heart rate (FHR) monitoring has the potential to timely detect fetuses at risk and, if coupled with timely obstetric responses may save more newborns. Moyo is a new Doppler with nine crystals capable of monitoring FHR both intermittently and continuously.
AIM
OBJECTIVE
To assess women's and midwives' opinions on the use of Moyo for intrapartum FHR monitoring.
METHODS
METHODS
We conducted a cross-sectional study using a structured questionnaire to assess women's and midwives' perception. Women who gave birth at the hospital who used Moyo were interviewed using a questionnaire immediately before discharge from the hospital. Twenty-eight midwives who have been using Moyo for more than 6 months were also interviewed using a structured questionnaire. Data were analyzed using excel and result presented in figures.
RESULTS
RESULTS
In total 113 postpartum women who were monitored using Moyo were interviewed before discharge. Out of these, 46 (40.7%) were first-time mothers and the rest were multipara. In total, 95 women (84.1%) used Moyo and other devices for FHR monitoring, 81 (72%) said Moyo was better than Fetoscopes and handheld Doppler, two-third 75 (66.4%) felt that Moyo was comfortable and 93 (82.3%) would like Moyo to be used on them in the future. Out of 28 midwives, 11 (39.3%) used Moyo continuous only, 3 (10.7%) used Moyo intermittently only and 14 (50.0%) used both intermittent and continuous. Thirteen (46.4%) midwives prefer to use Moyo both intermittent and continuous. Sixteen (55.6%) said Moyo was effective, 21 (75%) felt comfortable to use Moyo, and 13 (46.4%) said Moyo was easy to use.
CONCLUSION
CONCLUSIONS
The majority of midwives and women who used Moyo felt that Moyo was comfortable for intrapartum FHR monitoring. Moyo can be used both intermittently and continuously depending on the user's preferences.
Identifiants
pubmed: 32256129
doi: 10.2147/MDER.S241741
pii: 241741
pmc: PMC7092687
doi:
Types de publication
Journal Article
Langues
eng
Pagination
87-92Informations de copyright
© 2020 Mdoe et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Lancet Glob Health. 2016 Feb;4(2):e98-e108
pubmed: 26795602
J Obstet Gynecol Neonatal Nurs. 2015 Sep-Oct;44(5):683-6
pubmed: 26183597
PLoS One. 2018 Oct 26;13(10):e0206295
pubmed: 30365564
Lancet. 2016 Feb 6;387(10018):587-603
pubmed: 26794078
BMC Pregnancy Childbirth. 2019 May 10;19(1):165
pubmed: 31077139
Int J Gynaecol Obstet. 2020 Feb;148(2):145-156
pubmed: 31646629
Cent Afr J Med. 1992 Dec;38(12):458-62
pubmed: 1340797
Pediatrics. 2012 May;129(5):e1238-43
pubmed: 22508912
BMJ Open. 2019 Jun 28;9(6):e030271
pubmed: 31256041
Int J Gynaecol Obstet. 2018 Dec;143(3):344-350
pubmed: 30120775
PLoS One. 2018 Oct 11;13(10):e0205698
pubmed: 30308040
BMJ Open. 2015 Jan 30;5(1):e006867
pubmed: 25636792
Int J Environ Res Public Health. 2019 Jan 24;16(3):
pubmed: 30678354
Lancet Glob Health. 2019 Jun;7(6):e710-e720
pubmed: 31097275
Int J Environ Res Public Health. 2018 Feb 09;15(2):
pubmed: 29425167